In addition, previous studies have reported that serum VAP-1 levels were higher in subjects with colorectal cancer compared to healthy volunteers, and that serum VAP-1 levels could serve as an independent prognostic biomarker (21). This evidence concerns the gene AOC3 and colorectal cancer.